These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

475 related items for PubMed ID: 19711117

  • 1. Biochemical and pathological correlates of cognitive and behavioural change in DLB/PDD.
    Francis PT.
    J Neurol; 2009 Aug; 256 Suppl 3():280-5. PubMed ID: 19711117
    [Abstract] [Full Text] [Related]

  • 2. Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.
    Jellinger KA.
    J Neural Transm (Vienna); 2018 Apr; 125(4):615-650. PubMed ID: 29222591
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Proteasome inhibition induces α-synuclein SUMOylation and aggregate formation.
    Kim YM, Jang WH, Quezado MM, Oh Y, Chung KC, Junn E, Mouradian MM.
    J Neurol Sci; 2011 Aug 15; 307(1-2):157-61. PubMed ID: 21641618
    [Abstract] [Full Text] [Related]

  • 5. Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes.
    Walker L, McAleese KE, Thomas AJ, Johnson M, Martin-Ruiz C, Parker C, Colloby SJ, Jellinger K, Attems J.
    Acta Neuropathol; 2015 May 15; 129(5):729-48. PubMed ID: 25758940
    [Abstract] [Full Text] [Related]

  • 6. [Pathological and clinical comparison of Parkinson’s disease dementia and dementia with Lewy bodies].
    Bencs V, Bencze J, Módis VL, Simon V, Kálmán J, Hortobágyi T.
    Orv Hetil; 2020 May 01; 161(18):727-737. PubMed ID: 32338488
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Regional differences in synaptic degeneration are linked to alpha-synuclein burden and axonal damage in Parkinson's disease and dementia with Lewy bodies.
    Frigerio I, Bouwman MMA, Noordermeer RTGMM, Podobnik E, Popovic M, Timmermans E, Rozemuller AJM, van de Berg WDJ, Jonkman LE.
    Acta Neuropathol Commun; 2024 Jan 03; 12(1):4. PubMed ID: 38173031
    [Abstract] [Full Text] [Related]

  • 9. Differential insular cortex subregional vulnerability to α-synuclein pathology in Parkinson's disease and dementia with Lewy bodies.
    Fathy YY, Jonker AJ, Oudejans E, de Jong FJJ, van Dam AW, Rozemuller AJM, van de Berg WDJ.
    Neuropathol Appl Neurobiol; 2019 Apr 03; 45(3):262-277. PubMed ID: 29797340
    [Abstract] [Full Text] [Related]

  • 10. Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies.
    Beyer MK, Larsen JP, Aarsland D.
    Neurology; 2007 Aug 21; 69(8):747-54. PubMed ID: 17709706
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia.
    Fujishiro H, Iseki E, Higashi S, Kasanuki K, Murayama N, Togo T, Katsuse O, Uchikado H, Aoki N, Kosaka K, Arai H, Sato K.
    Neurosci Lett; 2010 Dec 03; 486(1):19-23. PubMed ID: 20851165
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Neuropsychiatric symptoms and α-Synuclein profile of patients with Parkinson's disease dementia, dementia with Lewy bodies and Alzheimer's disease.
    Bougea A, Stefanis L, Paraskevas GP, Emmanouilidou E, Efthymiopoulou E, Vekrelis K, Kapaki E.
    J Neurol; 2018 Oct 03; 265(10):2295-2301. PubMed ID: 30083953
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Reduction of RPT6/S8 (a Proteasome Component) and Proteasome Activity in the Cortex is Associated with Cognitive Impairment in Lewy Body Dementia.
    Alghamdi A, Vallortigara J, Howlett DR, Broadstock M, Hortobágyi T, Ballard C, Thomas AJ, O'Brien JT, Aarsland D, Attems J, Francis PT, Whitfield DR.
    J Alzheimers Dis; 2017 Oct 03; 57(2):373-386. PubMed ID: 28269775
    [Abstract] [Full Text] [Related]

  • 17. Lewy-like aggregation of α-synuclein reduces protein phosphatase 2A activity in vitro and in vivo.
    Wu J, Lou H, Alerte TN, Stachowski EK, Chen J, Singleton AB, Hamilton RL, Perez RG.
    Neuroscience; 2012 Apr 05; 207():288-97. PubMed ID: 22326202
    [Abstract] [Full Text] [Related]

  • 18. Novel clinicopathological characteristics differentiate dementia with Lewy bodies from Parkinson's disease dementia.
    Hansen D, Ling H, Lashley T, Foley JA, Strand C, Eid TM, Holton JL, Warner TT.
    Neuropathol Appl Neurobiol; 2021 Feb 05; 47(1):143-156. PubMed ID: 32720329
    [Abstract] [Full Text] [Related]

  • 19. High discriminatory ability of peripheral and CFSF biomarkers in Lewy body diseases.
    Bougea A, Stefanis L, Emmanouilidou E, Vekrelis K, Kapaki E.
    J Neural Transm (Vienna); 2020 Mar 05; 127(3):311-322. PubMed ID: 31912280
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.